Ionis Pharmaceuticals (IONS) Return on Capital Employed Growth (1y) (2011 - 2026)

Ionis Pharmaceuticals (IONS) Return on Capital Employed Growth (1y) (2011 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE Growth (1y) (Qtr)
1 Oculis Holding AG 66,561.01 Bn 66,560.72 Bn - 1,648.00
2 Nanobiotix 1,912.79 Bn 1,912.72 Bn - -
3 Akari Therapeutics 1,045.06 Bn 1,045.06 Bn - 31,429.00
4 BeOne Medicines 469.79 Bn 465.00 Bn 1.35 Bn 1,805.00
5 Vertex Pharmaceuticals 122.95 Bn 115.70 Bn 2.59 Bn 2,503.00
6 Regeneron Pharmaceuticals 70.05 Bn 61.30 Bn 3.31 Bn -105.00
7 Belite Bio 62.62 Bn 62.62 Bn - -
8 Argenx Se 56.18 Bn 50.99 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - -3,457.00
10 Ionis Pharmaceuticals 9.32 Bn 7.40 Bn 243.11 Mn 506.00

Historic Data

Download Data
DateValue
Mar 31, 2026 506.00
Dec 31, 2025 210.00
Sep 30, 2025 114.00
Jun 30, 2025 176.00
Mar 31, 2025 -251.00
Dec 31, 2024 -331.00
Sep 30, 2024 746.00
Jun 30, 2024 279.00
Mar 31, 2024 379.00
Dec 31, 2023 486.00
Sep 30, 2023 -2,266.00
Jun 30, 2023 -1,749.00
Mar 31, 2023 -1,924.00
Dec 31, 2022 -1,761.00
Sep 30, 2022 1,342.00
Jun 30, 2022 1,041.00
Mar 31, 2022 1,021.00
Dec 31, 2021 670.00
Sep 30, 2021 -1,648.00
Jun 30, 2021 -1,605.00